top of page

The Stock Pulse - Nov. 21, 2025

Updated: Nov 23

*** Please see the bottom of this report for important disclaimers and disclosures.***

ree

ree

Three bulls: ALLE, MMS, and STE. One bear: BSX


ALLE, MMS, and STE show big bases as BSX struggles after bearish wedge

Allegion (ALLE), Maximus (MMS), and STERIS (STE) each show constructive long-term technical setups, with ALLE breaking out of a 2021–2025 cup-and-handle base and targeting 195 and 210, MMS strengthening within a multi-year triangle base with breakout potential above 92.50 toward 120 and 132, and STE extending higher from a major 2022–2025 base toward 285 and 345 while holding key breakout support. In contrast, Boston Scientific (BSX) has weakened, breaking down from a bearish wedge and exposing downside toward 90 and 86, with declining weekly moving averages creating resistance that may cap any rebounds.


Allegion (ALLE): Big cup and handle base favors upside to 195 and 210

ALLE is a building products stock that has broken out of a large 2021–2025 cup-and-handle base, supporting upside targets near 195 and 210. The recent pullback from the 180 area appears to be a potential retest of the breakout, with key support at 156 and 148–145, reinforced by the rising 26- and 40-week moving averages near 161 and 151, respectively. Holding above or near these levels keeps the bullish pattern intact.


Maximus (MMS): Holding key support firms up a developing 4-year+ big base 

MMS, a professional services stock, is firming up within a multi-year triangle base that began in early 2021 after successfully holding key support and weekly moving averages near 80–76. This strengthens the developing big base pattern and shifts attention to the triangle neckline near 92.50, where a decisive breakout would confirm the base and open upside potential toward 120 and 132.


STERIS (STE): Big base breakout and retest targets 285 initially and then 345

STE is a healthcare equipment and supplies stock with a breakout and retest from an early 2022 into late 2025 big base that suggests further upside to a tactical pattern count at 285 and the full big base target at 345. The pattern remains bullish above the 253–252 breakout area, reinforced by rising 13-, 26-, and 40-week moving averages spanning from 247 to 237. The late October low near 232 offers the next support.


Boston Scientific (BSX): Has rolled over with downside risk toward 90 and 86

BSX, a healthcare equipment and supplies stock, has rolled over after breaking down from a rising wedge in September, pointing to downside risk toward the early-October spike low at 90.69 and the April low at 85.98. The declining 13-, 26-, and 40-week moving averages provide an overhang at 100-102 and could limit any tactical rebounds ahead of chart resistances from 105.65 up to 109.50.


Monitor our “Straight from the Chart” blog for more stock and ETF charts


What is The Stock Pulse?


The Stock Pulse provides bullish and bearish stock and ETF ideas

The Stock Pulse highlights bullish and bearish technical setups across common stocks, ADRs, and ETFs. The report emphasizes weekly charts to reduce short-term noise and targets a three-to-six-month investment horizon. We analyze price action and trends from both an absolute and relative perspective. Our relative benchmark is typically the S&P 500. We focus on the technicals, we but encourage investors to evaluate the fundamentals before acting on the ideas presented in The Stock Pulse.


We can categorize these charts as follows:

·         Bullish leadership: Bullish absolute and bullish relative trends. This technical setup represents a confirmed bullish trend. It also can indicate a bullish momentum stock.

o    Actions to consider: Buy dips, hold longs, and avoid shorts. 

·         Bearish laggard: Bearish absolute and bearish relative trends. This technical setup represents a confirmed bearish trend. It also can indicate a bearish momentum stock.

o    Actions to consider: Sell rallies, hold shorts, and avoid longs.

·         Bullish weakening: A bullish absolute trend and a deteriorating to bearish relative trend. The stock has rallied but lags its benchmark. This lack of bullish relative confirmation provides a negative divergence, which is a potential bearish leading indicator for the absolute price chart.

o    Actions to consider: Protect or reduce absolute longs, consider relative shorts, and if aggressive, initialize an absolute short.

·         Bearish strengthening: A bearish absolute trend and an improving to bullish relative trend. The stock has declined, but it has dropped less than its benchmark. This lack of bearish relative confirmation provides a positive divergence, which is a potential bullish leading indicator for the absolute price chart.

o    Actions to consider: Protect or reduce absolute shorts, consider relative longs, and if aggressive, initialize an absolute long.


Key indicators

We rely weekly charts – both absolute and relative – with simple weekly moving averages (WMA) and Trend Scores to assess the technical condition of the stocks, ADRs, and ETFS highlighted in this note. In addition, we may also highlight other important indicators and well as provide technical screens.


Weekly moving averages show multiple timeframes on one chart

·         The slope of the moving average is more important than whether the price is above or below it

·         13-WMA: Quarterly and tactical trend

·         26-WMA: Half-year and intermediate trend

·         40-WMA: Longer-term trend and similar to the 200-day moving average

·         200-WMA: Long-term or macro trend


Trend Scores

·         Trend Score: Ranges from -10 to +10 and incorporates the 13-, 26-, and 40-WMAs. Higher scores indicate stronger trends with prices above rising WMAs. Lower scores indicate weaker trends with price below declining WMAs. Longer WMAs are more heavily weighted.

·         Long-term Trend Score: Ranges from -20 to +20 and includes the 13-, 26-, 40-, and 200-WMAs. Higher scores reflect stronger long-term uptrends, while lower scores indicate long-term downtrends. Longer WMAs carry more weight.

 

Three bullish stock charts: ALLE, MMS, and STE


Allegion (ALLE): Big cup and handle base favors upside to 195 and 210

ALLE is a building products stock that has broken out of a large 2021–2025 cup-and-handle base, supporting upside targets near 195 and 210. The recent pullback from the 180 area appears to be a potential retest of the breakout, with key support at 156 and 148–145, reinforced by the rising 26- and 40-week moving averages near 161 and 151, respectively. Holding above or near these levels keeps the bullish pattern intact.


Chart notes:

·         ALLE is building a potential 2023-2025 bottoming pattern relative to the S&P 500 (SPX).


Chart 1: Allegion PLC (ALLE) (top) and relative to the S&P 500 (bottom)



ree

Source: Optuma, Suttmeier Technical Strategies


Maximus (MMS): Holding key support firms up a developing 4-year+ big base  

MMS, a professional services stock, is firming up within a multi-year triangle base that began in early 2021 after successfully holding key support and weekly moving averages near 80–76. This strengthens the developing big base pattern and shifts attention to the triangle neckline near 92.50, where a decisive breakout would confirm the base and open upside potential toward 120 and 132.


Chart notes:

·         Although MMS remains within a long-term lagging trend vs. the SPX, the stock is building a late 2024 into late 2025 bottom relative to the SPX, which is a positive sign.


Chart 2: Maximus Inc. (MMS) (top) and relative to the S&P 500 (bottom)




ree

Source: Optuma, Suttmeier Technical Strategies


STERIS (STE): Big base breakout and retest targets 285 initially and then 345

STE is a healthcare equipment and supplies stock with a breakout and retest from an early 2022 into late 2025 big base that suggests further upside to a tactical pattern count at 285 and the full big base target at 345. The pattern remains bullish above the 253–252 breakout area, reinforced by rising 13-, 26-, and 40-week moving averages spanning from 247 to 237. The late October low near 232 offers the next support.


Chart notes:

·         Although STE remains within a lagging trend vs. the SPX, the stock is building a late 2024 into late 2025 bottom relative to the SPX, which is a positive sign.


Chart 3: STERIS PLC (STE) (top) and relative to the S&P 500 (bottom)



ree

Source: Optuma, Suttmeier Technical Strategies


One bearish stock chart: BSX


Boston Scientific (BSX): Has rolled over with downside risk toward 90 and 86

BSX, a healthcare equipment and supplies stock, has rolled over after breaking down from a rising wedge in September, pointing to downside risk toward the early-October spike low at 90.69 and the April low at 85.98. The declining 13-, 26-, and 40-week moving averages provide an overhang at 100-102 and could limit any tactical rebounds ahead of chart resistances from 105.65 up to 109.50.


Chart notes:

·         A bearish shift relative to the SPX corroborates the risk for deeper absolute price downside.

·         Absolute and relative trend scores (upper right chart) flipped bearish to confirm this bearish setup.


Chart 4: Boston Scientific Corp. (BSX) and relative to the S&P 500 (bottom)



ree

Source: Optuma, Suttmeier Technical Strategies

 

Suttmeier Technical Strategies, LLC (STS) provides financial commentary and market analysis for educational and informational purposes only. We are not registered investment advisors, and nothing published by STS should be considered personalized investment advice, a recommendation to buy or sell any security, or a solicitation to engage in investment activity. All content is impersonal and does not consider your individual financial circumstances. Past performance is not indicative of future results. Investing involves risk, and you should consult with a licensed financial advisor before making any investment decisions. STS or its representatives may hold positions in securities mentioned in our publications. Such holdings are subject to change without notice and do not constitute investment advice.

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page